Skip to main content
News

News

DENT First Site In the Country to Administer New ALS Treatment

Posted on: 08/15/2017

On Friday, August 11, DENT became the first site in the United States to administer the new FDA approved amyotrophic lateral sclerosis (ALS) specific treatment, Radicava. Radicava is the first ALS specific treatment in 22 years and gives new hope to ALS patients. We are excited to continue being on the forefront of innovative treatments in WNY.

Click here to learn more about this groundbreaking new treatment. https://www.mt-pharma-america.com/wp-content/uploads/2017/08/RADICAVA-Availability-Press-Release.pdf

Back to Article List